BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2855575)

  • 41. Perfusion and molecular modification of idoxuridine to alter its cerebrospinal fluid metabolism.
    Gutin PH; Prockop LD; Yip KF; Weinstein JD; Tsou KC
    J Pharm Sci; 1977 Sep; 66(9):1338-40. PubMed ID: 903879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The penetration of anti-infectives into the central nervous system.
    Kearney BP; Aweeka FT
    Neurol Clin; 1999 Nov; 17(4):883-900. PubMed ID: 10517933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uptake of 5(125I) iodo-2-deoxyuridine (IDU) in plasma and cerebrospinal fluid in a case of herpes encephalitis with a comparative study on the uptake in plasma, cerebrospinal fluid and brain tissue in dogs.
    Paulsen O
    Scand J Infect Dis; 1977; 9(2):85-9. PubMed ID: 197595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent studies on the antiviral and biochemical properties of 5-halo-5'-amino-deoxyribonucleosides.
    Prusoff WH; Ward DC; Lin TS; Chen MS; Shaiu GT; Chai C; Lentz E; Capizzi R; Idriss J; Ruddle NH; Black FL; Kumari HL; Albert D; Bhatt PN
    Ann N Y Acad Sci; 1977 Mar; 284():335-41. PubMed ID: 212979
    [No Abstract]   [Full Text] [Related]  

  • 45. The ins and outs of antiviral drug transport in the brain.
    Gallo JM
    J Neurovirol; 1997 Dec; 3(6):385-6. PubMed ID: 9475110
    [No Abstract]   [Full Text] [Related]  

  • 46. Free radical scavenger prodrugs--potentially potent brain penetrating agents.
    Benes L; Pronayová N
    Pharmazie; 1994 Jan; 49(1):69-70. PubMed ID: 8140136
    [No Abstract]   [Full Text] [Related]  

  • 47. Lipid solubility and drug penetration of the blood brain barrier.
    Oldendorf WH
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):813-5. PubMed ID: 4445171
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cerebral lipids in subacute encephalitis. Biochemical analysis of 2 cases].
    SZLIWOWSKI HB; CUMINGS JN
    Acta Neurol Psychiatr Belg; 1961 Feb; 61():153-61. PubMed ID: 13774628
    [No Abstract]   [Full Text] [Related]  

  • 49. Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes.
    Bray M; Di Mascio M; de Kok-Mercado F; Mollura DJ; Jagoda E
    Antiviral Res; 2010 Nov; 88(2):129-142. PubMed ID: 20709111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HM-PAO-imaging and herpes encephalitis.
    Cleator GM; Lewis AG; Klapper PE; Sharma HL; Smith AM
    Arch Virol; 1989; 109(3-4):263-8. PubMed ID: 2558636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple quantitative radioiodination of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by exchange labelling.
    Verbruggen A; Julien C; De Clercq E; De Roo M
    Int J Rad Appl Instrum A; 1986; 37(4):355-7. PubMed ID: 3021658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
    Tyler KL
    Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs in the brain--cellular imaging with receptor microscopic autoradiography.
    Stumpf WE
    Prog Histochem Cytochem; 2012 Mar; 47(1):1-26. PubMed ID: 22240062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penetration of the blood-brain barrier by the antiviral drug (E)-5-(2-iodovinyl)-2'-deoxyuridine in a rat model of herpes encephalitis.
    Klapper PE; Cleator GM; Bruce JM; Longson M
    Drug Des Deliv; 1988 Jul; 3(1):57-67. PubMed ID: 2855575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific neuro-radiological diagnosis of herpes encephalitis in an animal model.
    Cleator GM; Klapper PE; Lewis AG; Sharma HL; Longson M
    Arch Virol; 1988; 101(1-2):1-12. PubMed ID: 3415476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomes for targeted delivery of radioiodinated IVdU and 3-CH3-IVdU for non-invasive detection of herpes simplex virus encephalitis in mice.
    Stathaki S; Wiebe LI; Knaus EE; Rogers JA; Tovell D; Tyrrell DL
    Drug Des Deliv; 1988 Nov; 3(3):223-34. PubMed ID: 2855578
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.